| Kassandra Hyde, APRN | |
|
5777 E Mayo Blvd, Phoenix, AZ 85054-4502 | |
| (480) 342-3962 | |
| Not Available |
| Full Name | Kassandra Hyde |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist |
| Location | 5777 E Mayo Blvd, Phoenix, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003689720 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364S00000X | Clinical Nurse Specialist | 299655 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kassandra Hyde, APRN 4147 W Crocus Dr, Phoenix, AZ 85053-5314 Ph: () - | Kassandra Hyde, APRN 5777 E Mayo Blvd, Phoenix, AZ 85054-4502 Ph: (480) 342-3962 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the Board of Appeals of the European Patent Office (EPO) has ruled that claims of the Kreutzer-Limmer '945 (EP 1214945) patent meet needed requirements under European patent law. The '945 patent comprises broad claims covering the length and certain structural requirements for siRNAs that are important for advancement of RNAi therapeutics.
Researchers at Bascom Palmer Eye Institute, part of the University of Miami Miller School of Medicine, have identified a new molecule that induces the formation of abnormal blood vessels in the eyes of diabetic mice.
A deficiency in one of the immune system's enzymes affects the severity of autoimmune diseases such as MS, and explains why the course of these diseases can vary so much. New findings give an insight into how this enzyme deficiency can be diagnosed, and could lead to new medicines, reveals a thesis from the Sahlgrenska Academy.
Intra-Cellular Therapies, Inc. ("ITI") and Takeda Pharmaceutical Company Limited, today announced that they have entered into an exclusive collaboration to develop and commercialize selective phosphodiesterase type 1 (PDE1) inhibitors, discovered by ITI, for the treatment of cognitive impairment associated with schizophrenia. This agreement is targeted worldwide, but ITI has retained the option to co-promote with Takeda in the United States.
When looking for a new physician, patients are often encouraged to select those who are board certified or who have not made payments on malpractice claims. Yet these characteristics are not always a good predictor of which physicians will provide the highest quality medical care, according to a new study from the RAND Corporation, a nonprofit research organization, and the University of Pittsburgh School of Medicine.
› Verified 4 days ago
Lara Shleef, PA Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 750 E Thunderbird Rd Ste 1-3, Phoenix, AZ 85022 Phone: 602-682-7455 Fax: 602-218-6383 | |
Cathleen Murphy-taylor, Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1919 E Thomas Rd, Phoenix, AZ 85016 Phone: 602-509-6914 | |
Katie Marie Williams, CRNP Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 4545 E Shea Blvd, 175, Phoenix, AZ 85028 Phone: 866-662-4560 Fax: 877-561-7566 | |
Mrs. Frances Marie Hanumaiah, ACNS-BC Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 650 E Indian School Rd, Phoenix, AZ 85012 Phone: 602-277-5551 | |
Emily Jacobs, APRN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1747 E Northern Ave Unit 256, Phoenix, AZ 85020 Phone: 734-604-6014 | |
Ms. Patricia Kate Paradis, FNP-C Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 10046 N Metro Pkwy W, Suite 115, Phoenix, AZ 85051 Phone: 602-674-5515 |